Schedule 13G ownership disclosure

ROIVANT SCIENCES LTD SHS

Common Shares, par value $0.0000000341740141 per share · CUSIP: G76279101

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SB Investment Advisers (UK) Limited

    Shares: 40,315,127.00 · Class: 5.8%

  • SoftBank Vision Fund L.P.

    Shares: 40,315,127.00 · Class: 5.8%

  • SVF Holdings (UK) LLP

    Shares: 40,315,127.00 · Class: 5.8%

  • SVF Investments (UK) Limited

    Shares: 40,315,127.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-023531
Form type
SCHEDULE 13G/A
Filer
Roivant Sciences Ltd.
CIK
CIK 1635088
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub